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Abstract 
Accurate demographic functions help scientists define and understand longevity. We 
summarize a new demographic model, the Weon model, and show the application to the 
demographic data for Switzerland (1876-2002). Particularly, the Weon model simply 
defines the maximum longevity, which is induced in nature by the mortality dynamics. 
In this study, we reconsider the definition of the maximum longevity and the 
effectiveness for longevity by the combined effect of the survival and mortality 
functions. The results suggest that the mortality function should be zero at the 
maximum longevity, since the density function is zero but the survival function is not 
zero. Furthermore, the effectiveness for longevity can be maximized at the characteristic 
life by the complementarity between the survival and mortality functions, which 
suggests that there may be two parts of rectangularization for longevity. The historical 
trends for Switzerland (1876-2002) implies that there may be a fundamental limiting 
force to restrict the increase of the effectiveness. As a result, it seems that the density 
function is essential to define and understand the mortality dynamics, the maximum 
longevity, the effectiveness for longevity, the paradigm of rectangularization and the 
historical trends of the effectiveness by the complementarity between the survival and 
mortality functions. 
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1. Introduction 
The study of aging has traditionally been independently approached at two 
levels of biological organization: at the individual and sub-individual level by 
gerontologists interested in the physiology of human aging, and at the population level 
by demographers primarily interested in patterns of survival and mortality in human 
populations (Gohil and Joshi, 1998). Fundamental studies of the aging process have 
lately attracted the interest of researchers in a variety of disciplines, linking ideas and 
theories from such diverse fields as biochemistry to mathematics (Weitz and Fraser, 
2001). The way to characterize aging is to plot the increase in mortality rate with 
chronological age. The mortality rate is the probability that an individual who is alive at 
a particular age will die during the following age interval. The mortality rate can also be 
represented as the fraction of the population surviving to a particular age (or the survival 
rate) (Weon, 2004c).  
The fundamental law of population dynamics is the Gompertz law (Gompertz, 
1825), in which the human mortality rate increases roughly exponentially with 
increasing age at senescence. The Gompertz model is most commonly employed to 
compare mortality rates between different populations (Penna and Stauffer, 1996). 
However, no mathematical model so far, including the Gompertz model, has been 
suggested that can perfectly approximate the development of the mortality rate over the 
total life span (Kowald, 1999). Particularly in modern research findings, it seems to be 
obvious that the mortality rate does not increase according to the Gompertz model at the 
highest ages (Vaupel, 1997; Robine and Vaupel, 2002), and this deviation from the 
Gompertz model is a great puzzle to demographers, biologists and gerontologists. There 
is strong evidence from many developed countries that the rate of increase in mortality 
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decelerates at high ages. Many of the traditional mathematical models (for instance, the 
Gompertz, Weibull, Heligman & Pollard, Kannisto, Quadratic and Logistic models) for 
the mortality rate provide poor fits to empirical population data at the highest ages 
(Thatcher, Kannisto and Vaupel, 1998; Yi and Vaupel, 2003).  
We have recently found a useful model, the Weon model, derived from the 
Weibull model with an age-dependent shape parameter to describe the human survival 
and mortality curves (Weon, 2004a, 2004b, 2004c). In this paper, we summarize the 
new demographic model, the Weon model, and show the application to the 
demographic data for Switzerland from 1876 up to 2002. Especially, we reconsider the 
definition of the maximum longevity, the effectiveness for longevity, the new paradigm 
of rectangularization for longevity and the historical trends of the effectiveness by the 
complementarity or the combined effect of the survival and mortality functions. 
 
2. Materials and Methods 
 
2.1. Demographic functions 
Mortality distributions can be effectively summarized by any one of several 
complementary functions (Wilmoth, 1997). Three functions are particularly useful: the 
density function, the survival function and the mortality function as a function of age; 
Let f  be the (probability) density function describing the distribution of life spans in a 
population. The cumulative density function, F , gives the probability that an individual 
dies before surpassing age t  (especially in this case, we consider that the age t  is a 
continuous variable). The survival function, s , gives the complementary probability 
( Fs −= 1 ) that an individual is still alive at age t . The mortality function, m , is defined 
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as the ratio of the density and survival functions ( sfm /= ). Thus, the mortality 
function gives the probability density at age t  conditional on survival to that age. The 
mathematical, complementary relationships among the demographic functions are as 
follows, 
 
sdt
ds
m
1
×−=  (1) 
sm
dt
dsf ×=−=  (2) 
 
In life table notation, the probability of surviving to age x  (the age x  is actually a 
discrete variable), s , would be denoted as 0/ llx . The continuous density function, f , 
would be replaced by the discrete function, xd  (or 0/ ld x ), which gives the number (or 
population) of life table deaths in age interval from x  to 1+x . Finally, the mortality 
function, m , would be written in the life table as xm  and is known to demographers and 
actuaries as the force of mortality. 
 
2.2. Demographic data 
Demographic data, the period life tables (for all sexes, 1x1) and the death rate 
data for the years of 1876-2002 for Switzerland, were taken from the Human Mortality 
Database (available at http://www.mortality.org). The age dependence of the shape 
parameter intrinsically makes the survival and mortality functions complex and difficult 
for modeling. Roughly a linear expression for the shape parameter is useful for ages 0-
80 (Weon, 2004a, 2004b, 2004c). For the best fits to the demographic data over the total 
life span; a cubic or a quartic expression is appropriate for ages 0-20, a linear or a 
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quadratic expression is appropriate for ages 20-80 and a quadratic expression is 
appropriate for ages 80+ (Weon, 2004c). 
 
3. Weon model 
In recent a new concept, model, methodology and principle for studying human 
longevity in terms of demographic basis have been introduced, developed and 
established by Weon (2004a, 2004b, 2004c). We call the new model the “Weon model” 
(Weon, 2004c), which is modified from the Weibull model with an age-dependent 
shape parameter. This section summarizes the concept, model, methodology, generality, 
definition of the mathematical limit of longevity (the maximum longevity) and 
complementarity principle on longevity by the Weon model and shows the application 
to the demographic data for Switzerland. 
 
3.1. Concept 
The original concept was obtained as follows: typical human survival curves 
show i) a rapid decrease in survival in the first few years of life and ii) a relatively 
steady decrease and then an abrupt decrease near death thereafter. Interestingly, the 
former behaviour resembles the Weibull survival function with 1<β  and the latter 
behaviour seems to follow the case of 1>>β . With this in mind, it could be assumed 
that shape parameter is a function of age (Weon, 2004b). The new model is completely 
different from the Weibull model in terms of the ‘age dependence of the shape 
parameter’. It is especially noted that the shape parameter can indicate a ‘rectangularity’ 
of the survival curve. The reason for this is that as the value of the shape parameter 
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becomes a high value, the shape of the survival curve approaches a further rectangular 
shape (Weon, 2004a). 
 
3.2. Model 
The Weon model is derived from the Weibull survival function and it is simply 
described by two parameters, the age-dependent shape parameter and the characteristic 
life. The age-dependent shape parameter enables us to model the survival and mortality 
functions and it is expressed as follows, 
 
))/(exp( βαts −=  (3) 
])/ln([)/(
dt
d
t
t
tm
β
α
β
α β ×+×=  (4) 
 
where α  denotes the characteristic life (or the scale parameter, α=t  when 
)1exp(−=s ) and β  denotes the shape parameter as a “function of age”. The Weon 
model is completely different with the Weibull model in the age dependence of the 
shape parameter. The fact that the shape parameter for humans is a function of age is 
valid with a certain degree of universality in many countries (Weon, 2004a, 2004b, 
2004c). The density function by the Weon model can be expressed the multiplication of 
the equation (3) and (4) by the mathematical relationship of ‘ smf ×= ’. 
 
3.3. Methodology 
We could evaluate the age dependence of the shape parameter to determine an 
adequate mathematical expression of the shape parameter, after determination of the 
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characteristic life graphically in the survival curve. Conveniently, the value of the 
characteristic life is always found at the duration for survival to be ‘ )1exp(− ’, this is 
known as the characteristic life. This feature gives the advantage of looking for the 
value of α  simply by graphical analysis of the survival curve. In turn, with the 
observed value of α , we can plot the shape parameter as a function of age by the 
mathematical equivalence of ‘ )/ln(/)lnln( αβ ts−= ’. If β  is not constant with age, 
this obviously implies that ‘ β  is a function of age’. For example, we can see the age 
dependence of the shape parameter for Switzerland (2002) in Fig. 1 when 98.86=α  
years. 
In empirical practice, we could successfully use a polynomial expression for 
modeling the shape parameter as a function of age: ...2210 +++= tt ββββ , where the 
associated coefficients could be determined by a regression analysis in the plot of shape 
parameter curve. And thus, the derivative of β  is obtained as follows: 
...2/ 21 ++= tdtd βββ , which indicates again that the shape parameter for humans is a 
function of age. Roughly a linear expression is useful for ages 0-80. But for the best fits 
to the demographic data over the total life span; a cubic or a quartic expression is 
appropriate for ages 0-20, a linear or a quadratic expression is appropriate for ages 20-
80 and a quadratic expression is appropriate for ages 80+ (Weon, 2004c). 
On the other hand, β  mathematically approaches infinity as the age t  
approaches the value of α  or the denominator ‘ )/ln( αt ’ approaches zero. This feature 
of β  can leave ‘trace of α ’ in the plot of β , so we can observe variations of β  and α  
at once in the plot of the shape parameters. If β  (except for the mathematical 
singularity or trace of α ) can be expressed by an adequate mathematical function, the 
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survival and mortality functions can be calculated by the mathematically expressed β . 
Only two parameters, α  and β , determine the survival and mortality functions. In the 
case of Switzerland (2002), when the characteristic life is evaluated to be 86.98 years, 
the trace of α  can be observed at the age 87 near the characteristic life in Fig. 1. 
 
3.4. Generality 
The Gompertz model (Gompertz, 1825) and the Weibull model (Weibull, 1951) 
are the most generally used models at present (Gavrilov and Gavrilova, 2001). 
Interestingly, the Gompertz model is more commonly used to describe biological 
systems, whereas the Weibull model is more commonly applicable to technical devices 
(Gavrilov and Gavrilova, 2001). In the previous paper (Weon, 2004c), we could see that 
the traditional models, the Gompertz and Weibull models, may be generalized by the 
Weon model on the basis of the fact that shape parameter is a function of age by the 
approximate relationship of ‘ β∝mln ’ after adulthood (for ages ~20+) (Weon, 2004c). 
The Weon model approximates the Gompertz model when ‘ t∝β ’ and the Weibull 
model when ‘ =β constant’. We could see that the Gompertz model is a special case of 
a linear expression for β  and the Weibull model is a special case of a constant shape 
parameter. Particularly, the mortality rate would deviate from the Gompertz model 
when β  shows a non-linear behavior (before age ~20 or after age 80). Thus, β  is a 
measure of the deviation from the Gompertz model (Weon, 2004c). 
Particularly for aging patterns, it is the age dependence of the shape parameter 
that distinguishes humans from technical devices. It seems to show the difference 
between humans and technical devices in terms of ‘robustness’. The fundamental 
difference for robustness between biological systems and technical devices is obvious 
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(Gavrilov and Gavrilova, 2001). In the previous papers (Weon, 2004a, 2004b, 2004c), 
the age-dependent shape parameter is changed from approximately 0.5 to 10 with age 
for the typical demographic curves. This feature is in great contrast to technical devices 
typically having a constant shape parameter (Nelson, 1990). We attribute the age 
dependence of the shape parameter to the resistance to aging, or the nature (the 
homeostasis and the adaptation) of biological systems to maintain stability and to 
survive (Weon, 2004a). A fundamental principle related to the age-dependent shape 
parameter for humans was suggested in the recent paper (Weon, 2004c), which will be 
explained in the section 3.6. 
 
3.5. Mathematical limit of longevity (maximum longevity) 
In general, the mortality rate should be mathematically positive ( 0>m ). 
Therefore, the criterion for the mathematical limit of longevity, implying the maximum 
longevity which is able to be determined by the mortality dynamics in nature, can be 
given by (Weon, 2004c), 
 
)/ln( α
ββ
ttdt
d
−>  (5) 
 
We successfully used a quadratic expression for the description of the shape parameter 
after age 80. For example, see the case of Switzerland (2002) from age 80 to 109 in Fig. 
2. Interestingly, the quadratic coefficient ( 2β ) is important to evaluate the mathematical 
limit of longevity, since it determines the slope with age in the derivative ( t21 2ββ + ) of 
the quadratic expression of the shape parameter (Weon, 2004c).  
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Specifically, the mortality curves for higher ages (110+) are important to 
understand the human longevity. According to the Weon model, the quadratic 
expression for ages 80-109 is valid with a certain degree of university in many modern 
developed countries, which enables us to predict that the mortality rate decreases after a 
plateau around ages 110-115 and the mathematical limit of longevity emerges around 
ages 120-130 (Weon, 2004c). If the quadratic expression is valid for ages 110+, we are 
able to predict the mortality rate at the highest ages. The pattern of the mortality 
dynamics (deceleration, plateau and decrease) at the highest ages by the Weon model is 
consistent with the other assertions (for instance, Vaupel et al., 1998; Robine and 
Vaupel, 2002; Helfand and Inouye, 2002). 
 
3.6. Complementarity principle on longevity 
In recent we suggested a fundamental principle on longevity (Weon, 2004c). We 
wish to explain it in brief. The essence of the Weon model is the age dependence of the 
shape parameter. What is the origin of the age-dependent shape parameter? According 
to the Weon model, in principle for the highest value of s  or for longevity at all times, 
the shape parameter should be variable according to the characteristic life; “for 
longevity, β  increases at α<t  but it decreases at α>t .” See an example of the 
longevity tendency in Fig. 3. This is attributable to the nature of biological systems to 
strive to survive healthier and longer. According to the Weon model, empirically the 
quadratic coefficient ( 2β ) indicates the decrease of β  at α>t . Thus, the longevity 
tends to increase with increasing 2β . On the other hand, we could see that the mortality 
dynamics (deceleration, plateau and decrease) are a consequence of the decrease of the 
shape parameter at α>t . According to the Weon model, the quadratic expression is 
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obviously related with the mortality dynamics at α>t , which induces the mathematical 
limit (the mortality rate to be mathematically zero, implying the maximum longevity). 
Interestingly, the mathematical limit tends to decrease with increasing quadratic 
coefficient ( 2β ). It seems that the mathematical limit decreases as the longevity 
increases, which shows “complementary” aspects. It is very interesting that the reason 
for longevity, especially in terms of the decrease of the shape parameter for ages after 
characteristic life, may be the reason for limit of longevity in nature (Weon, 2004c). 
 
4. Results and Discussion 
In this study, it seems to be obvious that the mortality function ( m ) is 
susceptible to the density function ( dtdsf /−= ) before age ~60 but it is sensitive to the 
reciprocal of the survival function ( s/1 ) thereafter. However, the density function 
( dtdsf /−= ) seems to drive again the mortality function ( m ) to decelerate at the 
highest ages. See an example for Switzerland (2002) in Fig. 4. According to the Weon 
model, the quadratic expression for the shape parameter at ages 80-109 results in that 
the mortality function is zero at the maximum longevity by the mortality dynamics in 
nature (Weon, 2004c). It seems that the density function is essential to understand the 
mortality dynamics. Especially in this study, we reconsider the definition for the 
maximum longevity and the demographic meaning of the density function by the 
complementarity between the survival and mortality functions. The demographic 
analysis for Switzerland (1876-2002) supports the findings by the Weon model. In the 
following sections, we think about the definition of maximum longevity by the Weon, 
the effectiveness for longevity by the complementarity between the survival and 
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mortality functions, the new paradigm of rectangularization for longevity by the 
effectiveness and the historical trends of the effectiveness for Switzerland (1876-2002).  
 
4.1. Definition of maximum longevity 
In general, the term of “longevity” means the “duration of life”. In a sense, the 
“maximum longevity” can be used to mean the “maximum duration of life” of a given 
population. However, what we know is the “maximum age at death”, which means the 
oldest age at death observed in a given population during a given time period (Vallin 
and Meslé, 2001). Perhaps the most common notion of a limit in the study of human 
longevity is the limited-life-span hypothesis, which states that there exists some age ω  
beyond which there can be no survivors. This hypothesis can be expressed by any one 
of the following three formulas (Wilmoth, 1997): “ 0=f , 0=s  or ∞=
→
m
t ω
lim  ( ω≥t ).” 
By the way, according to the Weon model, the survival function is not zero, although it 
has extremely low values at the highest ages, but that the mortality function can be zero 
at the maximum longevity. See an example for Switzerland in Fig. 5. The survival 
curves for 1876 and 2002 are not zero when they are extrapolated by the estimation of 
the shape parameters for ages 80-109. Therefore, the Weon model suggests that the 
maximum longevity can be defined as follows: “at ω=t , 0=f  and 0=m , because of 
0≠s .” 
If that is the case, why the mortality rate approaches zero at the maximum 
longevity in the Weon model? We think about what will happen to the survival rate at 
the maximum longevity. In fact the survival rate approaches zero, but it is not zero. The 
survival function is a kind of cumulative probability function as the complementary 
function of the cumulative density function ( Fs −= 1 ), indicating the probability of 
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survival beyond age t . Even at the maximum longevity (ω ), the survival function need 
not be always zero. Instead, the decrease rate of the survival function with age 
( dtds /− ; the minus indicates the decrease) should be zero at the maximum longevity. 
This means that the density function ( dtdsf /−= ) should be zero and thus the 
mortality function ( sfm /= ) should be zero at the maximum longevity, since the 
survival function is not zero ( 0≠s ). Consequently, the maximum longevity can be 
simply defined by the following simple mathematical expression, 
 
0=−
dt
ds
 (6) 
 
This simple mathematical expression for the maximum longevity makes sense and 
comprehends the definitions by the density and mortality functions as follows: “at ω=t , 
0=f  and 0=m , because of 0≠s .” The values for the maximum longevity calculated 
from the equation (5) and (6) are mathematically identical.  
We confirm the fact that the mortality function should be zero at the maximum 
longevity, since the density function is zero but the survival function is not zero at the 
moment. The functions beyond the maximum longevity have no reality. See an example 
for modeling the mortality function for Switzerland (2002) in Fig. 6. The mortality 
function extrapolated by the Weon model approaches zero at the maximum longevity, 
which is due to the nature of the density function: That is, the decrease rate of the 
survival function with age ( dtds /− ) or the density function should be zero at the 
maximum longevity. 
 
14 
4.2. Effectiveness for longevity 
It seems that the density function indicates the effectiveness for longevity 
between the survival and mortality functions, smf ×= , since the mortality rate tends 
to increase with decreasing the survival rate, which is due to the complementarity 
between the survival and mortality functions; “For longevity, individuals tend to reduce 
the mortality rate but strive to improve the survival rate.” It is expected that there may 
exist the ‘maximum’ effectiveness between the survival and mortality rates at the 
‘characteristic life’. See an example for Switzerland (2002) in Fig. 7. The effectiveness 
for longevity is maximized at the characteristic life (α ~87 years) and it is zero at the 
maximum longevity (ω ~124 years) for Switzerland (2002). 
 
4.3. Two-part rectangularization 
If that is the case, it can be suggested that since the most effective combination 
between the survival and mortality functions for longevity occurs at the characteristic 
life, there may be two parts of rectangularization for longevity as shown in Fig. 8 as 
follows: The survival function is rectangularized by the increase of the shape parameter 
before characteristic life ( α~0 ) – it is the first part. The survival function is 
rectangularized by the decrease of the shape parameter after characteristic life ( ωα ~ ) 
– it is the second part. The first and second parts can be overlapped as one 
rectangularization as the characteristic life approaches the maximum longevity 
( ωα → ). This paradigm of rectangularization for longevity makes sense and 
comprehends the conventional paradigm of rectangularization (Fried, 1980; Eakin and 
Witten, 1995).  
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4.4. Historical trends 
The historical trends of the density function for Switzerland from 1876 up to 
2002 are seen in Fig. 9. It tells the trends of the effectiveness for longevity by increasing 
the survival rate and decreasing the mortality rate over time. The density function shifts 
to the right and upward direction, which indicates that the most effective combination 
between the survival and mortality functions for longevity effectively increases as the 
characteristic life increases. However, it seems that the exponential decrease rates of the 
density function after the characteristic life does not significantly increases over time. 
This implies that a fundamental limiting force may restrict the effectiveness for 
longevity over time. It is attributed to the complementarity principle on longevity; “for 
longevity, β  increases at α<t  but it decreases at α>t , resulting in that the 
mathematical limit (the maximum longevity) decreases as the longevity increases in 
nature (Weon, 2004c)”.  
 
5. Conclusions 
In this paper, we summarize the new demographic model, the Weon model, and 
show the application to the demographic data for Switzerland (1876-2002). In this study, 
it seems to be obvious that the density function is essential to understand the mortality 
dynamics. We reconsider the definition of maximum longevity, the effectiveness for 
longevity by the complementarity between the survival and mortality functions, the new 
paradigm of rectangularization for longevity by the effectiveness and the historical 
trends of the effectiveness for Switzerland (1876-2002). The results suggest that the 
mortality function should be zero at the maximum longevity, since the density function 
is zero but the survival function is not zero. Furthermore, the effectiveness for longevity 
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can be maximized at the characteristic life by the complementarity between the survival 
and mortality functions. Since the most effective combination between the survival and 
mortality functions for longevity occurs at the characteristic life, there may be two parts 
of rectangularization for longevity according to the characteristic life. The historical 
trends for Switzerland (1876-2002) tells that the most effective combination between 
the survival and mortality functions for longevity effectively increases as the 
characteristic life increases over time, however the exponential decrease rates of the 
density function after the characteristic life does not significantly increases, which 
implies that a fundamental limiting force may restrict the effectiveness for longevity. As 
a result, it seems that the density function is essential to define and understand the 
mortality dynamics, the maximum longevity, the effectiveness for longevity, the 
paradigm of rectangularization and the historical trends of the effectiveness by the 
complementarity between the survival and mortality functions. 
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Fig. 1. The shape parameter as a function of age for Switzerland (2002) when the 
characteristic life is 86.98 years. 
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Fig. 2. Modeling the shape parameter as a quadratic expression between ages 80-109 for 
Switzerland (2002). 
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Fig. 3. Tendency for longevity by adapting the shape parameter around the 
characteristic life. 
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Fig. 4. Complementarity of the demographic functions, the survival, mortality and 
density functions as a function of age for Switzerland (2002). 
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Fig. 5. Comparison between the data of the survival rate and the model of the survival 
function through modeling the shape parameter for Switzerland (1876 and 2002). 
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Fig. 6. Comparison between the data of the mortality rate and the model of the mortality 
function through modeling the shape parameter for Switzerland (2002). 
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Fig. 7. Comparison between the data of the density function and the model through 
modeling the survival and mortality functions for Switzerland (2002). 
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Fig. 8. Demonstration of two parts of rectangularization for longevity. 
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Fig. 9. Historical trends of the effectiveness or the density function for Switzerland. 
